Neuronal Hormones and the Sympathetic/Parasympathetic Regulation of the Heart

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  2016-11-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-12-803111-7.00008-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Adrenal G protein-coupled receptor kinase-2 in regulation of sympathetic nervous system activity in heart failure.

  2015cited by this paper
• Influence of Number of Sets on Blood Pressure and Heart Rate Variability After a Strength Training Session

  2015cited by this paper
• The role of clock genes and circadian rhythm in the development of cardiovascular diseases

  2015cited by this paper
• O-Linked β-N-acetylglucosamine (O-GlcNAc) Acts as a Glucose Sensor to Epigenetically Regulate the Insulin Gene in Pancreatic Beta Cells*

  2015cited by this paper
• Autonomic and endocrine control of cardiovascular function.

  2015cited by this paper
• Aerobic training normalizes autonomic dysfunction, HMGB1 content, microglia activation and inflammation in hypothalamic paraventricular nucleus of SHR.

  2015cited by this paper
• Metabolic syndrome: a sympathetic disease?

  2015cited by this paper
• Evidence based application of BNP/NT-proBNP testing in heart failure.

  2015cited by this paper
• GPCR signaling and cardiac function.

  2015cited by this paper
• Daylight savings time and myocardial infarction

  2014cited by this paper
• Biomarkers and heart disease.

  2014cited by this paper
• Negative Impact of &bgr;-Arrestin-1 on Post-Myocardial Infarction Heart Failure via Cardiac and Adrenal-Dependent Neurohormonal Mechanisms

  2014cited by this paper
• Heart rate variability and the metabolic syndrome: a systematic review of the literature

  2014cited by this paper
• Pharmacogenetics of cardiac inotropy.

  2014cited by this paper
• Heart Rate and the Cardiometabolic Risk

  2013cited by this paper
• Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy

  2013cited by this paper
• Incidence of myocardial infarction with shifts to and from daylight savings time.

  2013cited by this paper
• Highlights in clinical autonomic neurosciences: treatment insights for postural tachycardia syndrome and inappropriate sinus tachycardia.

  2013cited by this paper
• Postural Tachycardia Syndrome (POTS)

  2013cited by this paper
• Baroreflex function in females: changes with the reproductive cycle and pregnancy.

  2012cited by this paper
• Links between Metabolic Syndrome and Cardiovascular Autonomic Dysfunction

  2012cited by this paper
• Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknown.

  2012cited by this paper
• GRK2 inhibition in heart failure: something old, something new.

  2012cited by this paper
• Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels.

  2011cited by this paper
• Autonomic imbalance: prophet of doom or scope for hope?

  2011cited by this paper
• O-GlcNAcylation, Novel Post-Translational Modification Linking Myocardial Metabolism and Cardiomyocyte Circadian Clock*

  2011cited by this paper
• GRK2 as a novel gene therapy target in heart failure.

  2011cited by this paper
• Sleep and hypertension.

  2010cited by this paper
• Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure.

  2010cited by this paper
• Improvements in heart rate variability with exercise therapy.

  2010cited by this paper
• β2-Adrenergic Receptor Redistribution in Heart Failure Changes cAMP Compartmentation

  2010cited by this paper
• Insomnia with short sleep duration and mortality: the Penn State cohort.

  2010cited by this paper
• Pregnancy and the endocrine regulation of the baroreceptor reflex.

  2010cited by this paper
• Reduction of Sympathetic Activity via Adrenal-targeted GRK2 Gene Deletion Attenuates Heart Failure Progression and Improves Cardiac Function after Myocardial Infarction*

  2010cited by this paper
• An adrenal β-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo

  2009cited by this paper
• The effect of aerobic training and cardiac autonomic regulation in young adults.

  2009cited by this paper
• Modulation of adrenal catecholamine secretion by in vivo gene transfer and manipulation of G protein-coupled receptor kinase-2 activity.

  2008cited by this paper
• Postural tachycardia syndrome.

  2008cited by this paper
• Calcium cycling and signaling in cardiac myocytes.

  2008cited by this paper
• American Heart Association/american College of Cardiology Foundation/heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardi

  2008cited by this paper
• Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.

  2008cited by this paper
• Rapid attenuation of circadian clock gene oscillations in the rat heart following ischemia-reperfusion.

  2007cited by this paper
• Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.

  2007cited by this paper
• Cardiac α1-adrenergic drive in pathological remodelling

  2007cited by this paper
• Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure

  2007cited by this paper
• Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation.

  2007cited by this paper
• Postural orthostatic tachycardia syndrome

  2007cited by this paper
• The sympathetic nervous system and the metabolic syndrome.

  2007cited by this paper
• Sympathetic Overdrive and Cardiovascular Risk in the Metabolic Syndrome

  2006cited by this paper
• The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program.

  2006cited by this paper
• GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling

  2006cited by this paper
• Effect of α1-adrenergic receptors in cardiac pathophysiology

  2006cited by this paper
• Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

  2005cited by this paper
• The intrinsic circadian clock within the cardiomyocyte.

  2005cited by this paper
• Metabolic syndrome: therapeutic considerations.

  2005cited by this paper
• Phospholemman-Phosphorylation Mediates the β-Adrenergic Effects on Na/K Pump Function in Cardiac Myocytes

  2005cited by this paper
• Role of gap junctions in the propagation of the cardiac action potential.

  2004cited by this paper
• Basic mechanisms of cardiac impulse propagation and associated arrhythmias.

  2004cited by this paper
• Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes.

  2004cited by this paper
• Circadian Variation of Cardiac K+ Channel Gene Expression

  2003cited by this paper
• Total sleep deprivation elevates blood pressure through arterial baroreflex resetting: a study with microneurographic technique.

  2003cited by this paper
• Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes.

  2003cited by this paper
• What Is the Role of &bgr;-Adrenergic Signaling in Heart Failure?

  2003cited by this paper
• Heart rate variability in heart failure.

  2003cited by this paper
• Seven-transmembrane-spanning receptors and heart function

  2002cited by this paper
• Feedback Inhibition of Catecholamine Release by Two Different &agr;2-Adrenoceptor Subtypes Prevents Progression of Heart Failure

  2002cited by this paper
• Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough.

  2002cited by this paper
• Extensive and divergent circadian gene expression in liver and heart

  2002cited by this paper
• Alterations of the circadian clock in the heart by streptozotocin-induced diabetes.

  2002cited by this paper
• Clock Genes in the Heart: Characterization and Attenuation With Hypertrophy

  2001cited by this paper
• Intrinsic Diurnal Variations in Cardiac Metabolism and Contractile Function

  2001cited by this paper
• Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.

  2001cited by this paper
• Angiotensin II and Its Metabolites Stimulate PAI-1 Protein Release From Human Adipocytes in Primary Culture

  2001cited by this paper
• Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes.

  2001cited by this paper
• Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level.

  2000cited by this paper
• Effects of a Residential Exercise Training on Baroreflex Sensitivity and Heart Rate Variability in Patients With Coronary Artery Disease: A Randomized, Controlled Study

  2000cited by this paper
• Changes in baroreceptor sensitivity for heart rate during normotensive pregnancy and the puerperium.

  2000cited by this paper
• The β2-Adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-Dependent coupling to phosphatidylinositol 3'-kinase

  2000cited by this paper
• Adrenergic and muscarinic receptors in the human heart.

  1999cited by this paper
• Opposing Effects of β1- and β2-Adrenergic Receptors on Cardiac Myocyte Apoptosis Role of a Pertussis Toxin–Sensitive G Protein

  1999cited by this paper
• Low- and high-level transgenic expression of β2-adrenergic receptors differentially affect cardiac hypertrophy and function in Gαq-overexpressing mice

  1999cited by this paper
• Heart rate variability during waking and sleep in healthy males and females.

  1999cited by this paper
• Role of sympathoadrenergic mechanisms in arrhythmogenesis.

  1999cited by this paper
• A family of hyperpolarization-activated mammalian cation channels

  1998cited by this paper
• Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A

  1997cited by this paper
• Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study.

  1996cited by this paper
• Regulation of phospholamban and troponin-I phosphorylation in the intact rat cardiomyocytes by adrenergic and cholinergic stimuli: roles of cyclic nucleotides, calcium, protein kinases and phosphatases and depolarization

  1995cited by this paper
• Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt.

  1994cited by this paper
• Heart rate variability and clinical cardiology.

  1994cited by this paper
• Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function.

  1993cited by this paper
• Heart rate variability during the acute phase of myocardial infarction.

  1992cited by this paper
• The G-protein-coupled receptor kinases beta ARK1 and beta ARK2 are widely distributed at synapses in rat brain

  1992cited by this paper
• Stability over time of heart period variability in patients with previous myocardial infarction and ventricular arrhythmias. The CAPS and ESVEM investigators.

  1992cited by this paper
• Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification.

  1992cited by this paper
• Stability over time of variables measuring heart rate variability in normal subjects

  1991cited by this paper
• Heart rate variability before and after myocardial infarction in conscious dogs at high and low risk of sudden death.

  1990cited by this paper
• Impulse propagation from the SA-node to the ventricles

  1987cited by this paper
• Mechanisms of arrhythmogenesis during myocardial ischemia and reperfusion: a perspective of our current understanding.

  1986cited by this paper
• Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

  1986cited by this paper
• Atrial natriuretic factor: a hormone produced by the heart.

  1985cited by this paper

• Cardiac contractility of the African sharptooth catfish, Clarias gariepinus: role of extracellular Ca2+, sarcoplasmic reticulum, and β-adrenergic stimulation

  2021cites this paper